By InvitationNot Applicable

Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile

Kosovo130 participantsStarted 2016-06-01

Plain-language summary

Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.

Who can participate

Age range20 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * residual hypermetropic, myopic refraction on pseudophakic patients * low visual acuity Exclusion Criteria: * active anterior segment pathologic features, * previous corneal or anterior segment surgery, * glaucoma, * retinal detachment

What they're measuring

Increase of visual acuity

Timeframe: 6 months

Trial details

NCT IDNCT04712318

SponsorEye Hospital Pristina Kosovo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-01

View on ClinicalTrials.gov More Pseudophakia trials